First tranche delivered, larger tranches en route: the same engine that just produced has visibly more already scheduled
The model's full reasoning — Q1 2024 call → NOWe need answer YES/NO. Need analyze transcript. Need identify engine with first tranche landed and larger tranches in motion same engine, remainder larger, management treats execution/timing. Need only transcript. Let's parse. Management discusses several: NanoKnife, mechanical thrombectomy (AngioVac/AlphaVac), Auryon, Med Device. Need find one where both conditions. NanoKnife: Q1 grew 36%, probes 35%. PRESERVE study enrolled final patient, data submission Q3 calendar 2024 for expanded indication. But that's clinical study, not business delivery? The landed portion is revenue growth in quarter. Larger tranches? They expect growth, but not necessarily committed. They say "We believe that NanoKnife has potential..." Not concrete committed. Also PRESERVE is study, not product sales. No. Mechanical thrombectomy: AngioVac declined but sequentially up. AlphaVac revenue $1.8M. APEX PE study 75% enrolled, expect PE indication around end calendar Q2 2024. That's future approval, not committed business. No. Auryon: Q1 revenue $11.1M, grew 25.7%. They have placements, shifting lasers. They plan launch catheters for small vessel DVT in 2025, pursue CAD indication, CE Mark in next few months. But continuation is future approvals/launches, not already in motion? CE Mark expected, not landed. No. Med Device: ports grew 22%, Solero. But that's routine? Not engine with larger tranches. Need find specific engine: Maybe "international businesses grew 26%" with partners. But no specific. Question asks "ONE identifiable engine of new business — such as a specific contract, program, product, facility, customer relationship, market, or expansion — for which BOTH: first tranche actually landed in just-reported period, and larger tranches already in motion behind it." Need management's own words establish landed portion real and recent, continuation already secured/in motion, remainder larger. Look for "we enrolled and treated our final patient in PRESERVE study" - that's a milestone, not business. No. Maybe "Auryon platform" - they have placements and revenue. But larger tranches? They say "We intend to launch catheters specially designed to allow Auryon to treat small vessel DVT in 2025." That's future, not in motion. "We are also pursuing plans to gain an indication for Auryon to treat coronary artery disease." Not committed.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| ASO | Academy Sports and Outdoors, Inc. | Q1 2024 | 2024-06-11 | C+ |
| ATAT | Atour Lifestyle Holdings Limited | Q1 2024 | 2024-05-23 | B+ |
| LINC | Lincoln Educational Services Corporation | Q1 2024 | 2024-05-06 | B+ |
| LTRX | Lantronix, Inc. | Q3 2024 | 2024-04-29 | C |
| E | Eni S.p.A. | Q1 2024 | 2024-04-24 | B+ |
| FRPH | FRP Holdings, Inc. | Q4 2023 | 2024-03-07 | C+ |
| ZLAB | Zai Lab Limited | Q4 2023 | 2024-02-28 | C |
| VMI | Valmont Industries, Inc. | Q4 2023 | 2024-02-22 | C |
| TBLA | Taboola.com Ltd. | Q3 2023 | 2023-11-08 | B+ |
| JLL | Jones Lang LaSalle Incorporated | Q3 2023 | 2023-11-02 | F |
| TEL | TE Connectivity Ltd. | Q4 2023 | 2023-11-01 | B |
| CLNE | Clean Energy Fuels Corp. | Q2 2023 | 2023-08-09 | C+ |
| LUCD | Lucid Diagnostics Inc. | Q1 2023 | 2023-05-16 | C+ |
| CEIX | CONSOL Energy Inc. | Q4 2022 | 2023-02-07 | B |
| ARE | Alexandria Real Estate Equities, Inc. | Q4 2022 | 2023-01-31 | C+ |
| SOL | ReneSola Ltd | Q3 2022 | 2022-12-01 | C+ |
| SYM | Symbotic Inc. | Q3 2022 | 2022-08-01 | B+ |
| CDMO | Avid Bioservices, Inc. | Q3 2022 | 2022-03-08 | B+ |
| DG | Dollar General Corporation | Q2 2021 | 2021-08-26 | A |
| DOV | Dover Corporation | Q2 2021 | 2021-07-20 | B+ |
| MAS | Masco Corporation | Q3 2018 | 2018-10-30 | C |
| FEIM | Frequency Electronics, Inc. | Q1 2019 | 2018-09-13 | B+ |
| SRDX | Surmodics, Inc. | Q3 2018 | 2018-08-06 | A |
| IRT | Independence Realty Trust, Inc. | Q2 2018 | 2018-08-02 | B |
| MGA | Magna International Inc. | Q1 2018 | 2018-05-10 | B+ |
| SATS | EchoStar Corporation | Q1 2018 | 2018-05-10 | C+ |
| RACE | Ferrari N.V. | Q3 2017 | 2017-11-02 | C+ |
| FLEX | Flex Ltd. | Q1 2018 | 2017-07-28 | F |
| HR | Healthcare Realty Trust Incorporated | Q1 2017 | 2017-05-08 | A |
| BDN | Brandywine Realty Trust | Q1 2017 | 2017-04-21 | C+ |
| WTS | Watts Water Technologies, Inc. | Q4 2016 | 2017-02-10 | B |
| PSX | Phillips 66 | Q4 2016 | 2017-02-03 | C+ |
| LBTYK | Liberty Global's | Q1 2016 | 2016-05-10 | C+ |
| GOGO | Gogo Inc. | Q1 2016 | 2016-05-06 | C+ |
| MTRX | Matrix Service Company | Q3 2016 | 2016-05-05 | D |
| CLF | Cleveland-Cliffs Inc. | Q1 2016 | 2016-04-29 | F |
| DD | DuPont de Nemours, Inc. | Q1 2016 | 2016-04-26 | B+ |
CDMO · Q3 2022 → YESThe question is about whether management describes ONE identifiable engine of new business that meets two criteria: NO The transcript describes the first phase of the Myford expansion as now operational and scheduling client projects, with management noting they are already utilizing the new space and that an extra $5 million is arguably in backlog attributable to it.
LINC · Q1 2024 → YESThe question is about whether management describes ONE identifiable engine of new business that meets two criteria: YES The transcript identifies the new-campus expansion strategy as the engine. East Point opened in Q1 with 29 starts and $90k revenue (first tranche, concrete and delivered).
LTRX · Q3 2024 → YESThe question is about whether management describes one identifiable engine of new business that meets two criteria: a first tranche has actually landed in the just-reported period, and larger tranches...